Project Details
Description
A Long-Term, Multi-Center, Open-Label Safety Study with Oral 20 or 40 Mg/d Doses of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients with Motor
| Status | Finished |
|---|---|
| Effective start/end date | 8/19/04 → 9/1/08 |
Funding
- LINEBERY RES ASSOC LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.